Serums
Creams & Moisturizers
Eye Care
Cleansers & Toners
Masks & Treatments
Complexion & Glow
Body & Bath
The Science
The molecule is only half the story. The dose is the other half.
Osmotics has built its formulas on copper peptides since 1998. Here is what the science says they do — and why the concentration on the back of the jar decides whether any of it happens.
The molecule
What a copper peptide actually is
A copper peptide is a small peptide — a short chain of amino acids — bound to a single copper ion. It occurs naturally in the body and was first isolated from human blood plasma in 1973 by Dr Loren Pickart. Levels of it in the skin fall sharply with age, which is part of why older skin repairs and renews more slowly.
In the decades of research since, the copper peptide has been shown to support the skin’s own structural machinery — the synthesis of collagen and elastin, and the signalling that tells skin to renew itself. It is one of the very few cosmetic actives with a genuine body of independent, peer-reviewed literature behind it, rather than a single supplier brochure.
What the research shows
Three things copper peptides are studied for
Firmness & structure
In laboratory studies, copper peptides support fibroblasts in producing collagen and elastin — the proteins that give skin its bounce and resilience, and that thin with age.
Renewal signalling
Genomic research indicates the copper peptide modulates the expression of a large number of human genes tied to the skin’s natural repair and regeneration pathways.
Antioxidant support
The molecule helps the skin cope with the oxidative stress of daily sun and pollution exposure, part of what drives visible ageing over time.
The part most brands skip
An ingredient only does what its study says — if it’s there at the studied strength
Almost any brand can put a celebrated active on an ingredient list. A pinch of it — enough to name on the box, far too little to do what the research showed — is what the industry politely calls “fairy dusting”. The study was run at a specific concentration. Below that concentration, the result on the page simply doesn’t belong to the product.
Osmotics formulates its actives at the level used in the research behind them — and in several products, above it. We don’t publish the exact percentages, because the batch formula is proprietary. What we publish is the discipline: where an active sits at or above its studied strength, we say so; where it sits below, we make no claim for it, even though it’s on the label.
The active is the headline. The dose is whether the headline is true.
How to read our evidence
Two kinds of proof — and we keep them apart
Skincare “proof” gets blurry on purpose. We keep the two kinds separate on every product page, so you always know which one you’re looking at.
Independent studies of the active itself — with a panel size, a duration, a placebo control and a measurement method — carried out at the concentration we use. This is real, citable science. Where the evidence is in vitro (cell cultures rather than volunteers), we label it as such and never dress it up as a result on skin.
What real users reported after four or eight weeks of using the finished product — the percentages and before/after photos you see on our pages. These reflect how people experienced the product; they are not instrumental measurements, and we present them as perception, never as clinical proof of the finished formula.
See the evidence, product by product
References. Pickart L. (1973) — first isolation of the copper tripeptide from human plasma. Maquart F.X. et al., FEBS Letters (1988) — stimulation of collagen synthesis in fibroblast cultures by the copper peptide. Pickart L. & Margolina A., Cosmetics (2017) — review of the copper peptide in skin regeneration.